New initiative will identify gaps in care, spur quality improvement in treating vulnerable patients WASHINGTON, Sept. 10, 2020 /PRNewswire/ — The American College of Cardiology, in partnership with Novo Nordisk Inc., is launching Transforming Cardiovascular Risk in Diabetes (TRANSFORM CVRiD), a new, two-year health care quality initiative to promote cardiovascular risk reduction and […]
Author: Ken Dropiewski
Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study…
Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation DUBLIN, Sept. 9, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility […]
AACC and CDC Partner to Improve Cardiovascular Disease Testing Around the World
WASHINGTON, Sept. 9, 2020 /PRNewswire/ — AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a new collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation that aims to expand lipid testing in resource-limited countries. Improving access […]
MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy
BRISBANE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced that the first patient has been dosed in the company’s Phase 2 clinical trial of danicamtiv (formerly MYK-491) in people with primary dilated cardiomyopathy (DCM) thought to be caused by genetic mutations of the sarcomere. Danicamtiv […]
Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System
Early successes in roll-out of world’s most complete solution for atrial fibrillation VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc. announced the first commercial procedures with the Globe Mapping and Ablation System. The Globe System is the most complete solution for the treatment of atrial fibrillation (AF) – the world’s most common heart rhythm disorder, […]
Bardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer
SEATTLE, Sept. 8, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as President and Chief Executive Officer, effective August 31, 2020. Hykes will also become a member of BardyDx’s Board of Directors. With over 28 years of experience in the […]
Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 /PRNewswire/ — Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Series A financing, which will be used to advance product development, support pre-clinical testing, and expand the team as the company furthers its […]
InspireMD Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study of CGuard Carotid Stent System
IDE Approval to Pave the Way for Pivotal Study of CGuard System for Carotid Artery Disease and Stroke Prevention in the United States TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke […]
MedHub Appoints Prof. Rafael Beyar, Co-Founder of Cordinus Vascular Robotics, to its Board of Directors
TEL AVIV, Israel, Sept. 8, 2020 /PRNewswire/ — MedHub Ltd, a medical technology company specializing in the development and commercialization of AI powered technologies that aid in the diagnosis of cardiac disease, announced today the appointment of Prof. Rafael Beyar as the Chairman of the company’s Board of Directors. As MedHub continues to execute on its go-to-market […]
CoreMap Wins National Science Foundation Phase I SBIR Award
Grant Will Support Continued Development of CoreMap’s Technology to Enable Curative, Patient-Specific Treatment of Atrial Fibrillation BURLINGTON, Vt., Sept. 08, 2020 (GLOBE NEWSWIRE) — CoreMap, Inc. announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF) to support development of […]
Recent
Popular
- No commented posts yet